Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Non-Invasive Radiological Predictors Of Portal Hypertension And Variceal Bleeding In Chronic Liver Disease Patients: A Prospective Cohort Study At Hayatabad Medical Complex, Peshawar

View through CrossRef
Background:Portal hypertension and variceal bleeding are leading causes of morbidity and mortality in chronic liver disease (CLD). Invasive tools remain the gold standard for risk assessment, but resource and patient constraints demand validated, non-invasive alternatives, especially in low- and middle-income settings. To determine the diagnostic and prognostic accuracy of non-invasive radiological predictors for portal hypertension and first variceal bleeding in patients with CLD at Hayatabad Medical Complex, Peshawar. Methods:A prospective cohort of 371 adults with cirrhosis was followed for 12 months (May 2024–May 2025). All patients underwent standardized assessment with transient elastography (FibroScan®), contrast-enhanced ultrasound, and MRI. Baseline liver stiffness measurement (LSM), spleen stiffness measurement (SSM), splenic size, portal vein diameter, and platelet count-to-spleen diameter ratio (PSR) were evaluated. Multivariable Cox regression and AUROC analyses identified predictors of portal hypertension and first variceal bleed. Results:Portal hypertension was present in 222/371 (59.8%) at baseline. Over 12 months, 54 patients (14.6%) developed a first variceal bleed. LSM >20 kPa (HR 3.31, 95% CI 2.01–5.44), SSM >46 kPa (HR 2.89, 95% CI 1.67–4.99), portal vein diameter >13 mm (HR 2.61, 95% CI 1.51–4.51), splenomegaly (HR 2.45, 95% CI 1.19–4.97), and PSR <909 (HR 2.38, 95% CI 1.32–4.28) independently predicted variceal bleeding. The combined non-invasive model achieved an AUROC of 0.88 (95% CI 0.83–0.92). Subgroup and sensitivity analyses confirmed robustness across etiology, sex, and Child-Pugh class. Conclusions:A combination of liver and spleen stiffness and simple ultrasound indices offers high diagnostic and prognostic accuracy for portal hypertension and variceal bleeding in CLD. Adoption of these non-invasive tools could significantly improve risk stratification and reduce the need for routine endoscopy, particularly in resource-limited settings.
Title: Non-Invasive Radiological Predictors Of Portal Hypertension And Variceal Bleeding In Chronic Liver Disease Patients: A Prospective Cohort Study At Hayatabad Medical Complex, Peshawar
Description:
Background:Portal hypertension and variceal bleeding are leading causes of morbidity and mortality in chronic liver disease (CLD).
Invasive tools remain the gold standard for risk assessment, but resource and patient constraints demand validated, non-invasive alternatives, especially in low- and middle-income settings.
To determine the diagnostic and prognostic accuracy of non-invasive radiological predictors for portal hypertension and first variceal bleeding in patients with CLD at Hayatabad Medical Complex, Peshawar.
Methods:A prospective cohort of 371 adults with cirrhosis was followed for 12 months (May 2024–May 2025).
All patients underwent standardized assessment with transient elastography (FibroScan®), contrast-enhanced ultrasound, and MRI.
Baseline liver stiffness measurement (LSM), spleen stiffness measurement (SSM), splenic size, portal vein diameter, and platelet count-to-spleen diameter ratio (PSR) were evaluated.
Multivariable Cox regression and AUROC analyses identified predictors of portal hypertension and first variceal bleed.
Results:Portal hypertension was present in 222/371 (59.
8%) at baseline.
Over 12 months, 54 patients (14.
6%) developed a first variceal bleed.
LSM >20 kPa (HR 3.
31, 95% CI 2.
01–5.
44), SSM >46 kPa (HR 2.
89, 95% CI 1.
67–4.
99), portal vein diameter >13 mm (HR 2.
61, 95% CI 1.
51–4.
51), splenomegaly (HR 2.
45, 95% CI 1.
19–4.
97), and PSR <909 (HR 2.
38, 95% CI 1.
32–4.
28) independently predicted variceal bleeding.
The combined non-invasive model achieved an AUROC of 0.
88 (95% CI 0.
83–0.
92).
Subgroup and sensitivity analyses confirmed robustness across etiology, sex, and Child-Pugh class.
Conclusions:A combination of liver and spleen stiffness and simple ultrasound indices offers high diagnostic and prognostic accuracy for portal hypertension and variceal bleeding in CLD.
Adoption of these non-invasive tools could significantly improve risk stratification and reduce the need for routine endoscopy, particularly in resource-limited settings.

Related Results

[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
PREDICTORS OF RE-BLEEDING AFTER OESOPHAGEAL VARICEAL BANDING IN CIRRHOTIC PATIENTS AT 4 WEEKS
PREDICTORS OF RE-BLEEDING AFTER OESOPHAGEAL VARICEAL BANDING IN CIRRHOTIC PATIENTS AT 4 WEEKS
Background: Acute upper gastrointestinal bleeding is a serious complication in cirrhotic patients. Without recommended management, recurrent bleeding happens in 30-40% within the n...
Carvidelol Vs Propanol for Secondary Prophylaxis of Variceal Hemorrhage in Liver Cirrhosis Patients
Carvidelol Vs Propanol for Secondary Prophylaxis of Variceal Hemorrhage in Liver Cirrhosis Patients
Propranolol and Carvedilol are the currently used medications for main prophylaxis of variceal bleeding. Objective: To investigate the efficacy of carvedilol vs propranolol for pre...

Back to Top